Cathelicidin-BF-30 clinically approved as new drug

BF-30 is a single chain polypeptide which contains 30 amino acid residues, with a molecular mass of 3637. First isolated by CAS Institute of Zoology in Kunming which has specialized in antimicrobial peptides derived from snakes and amphibians, the peptide has been approved for clinical treatment of vaginosis but is also studied as an antiviral agent.

CAS news release, December 18, 2018


Cathelicidin-BF-30 clinically approved as new drug
Scroll to top